← Back to home
Comparison · Analytics

pharmaverseadam vs simtrial

A side-by-side editorial comparison of pharmaverseadam and simtrial — release velocity, themes, recent moves, and the top alternatives to consider.

Shared themes:pharmaverse

pharmaverseadam vs simtrial: at a glance

Featurepharmaverseadamsimtrial
SectorAnalyticsAnalytics
Velocity score0.00.0
Sparks · 30d00
Top themespharmaverse, clinical-data, adam, test-dataclinical-trials, group-sequential, survival-analysis, simulation
Last editorial update1h ago49m ago
WebsiteVisit →Visit →

What is pharmaverseadam?

pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.

pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.

Read the full pharmaverseadam trajectory →

What is simtrial?

A fixed-design trial simulator grew a pluggable test framework, then spent a year proving the numbers

simtrial simulates time-to-event clinical trials and applies the tests used to analyse them — logrank, weighted logrank, MaxCombo, RMST, milestone. The 0.4.0 release turned it from a fixed-sample simulator into a group sequential one and standardised every test behind a common output contract, and the releases since have been about making that machinery correct and fast enough to run at scale. Version 1.0.0 arrived in June 2025 with the API settled and three vignettes explaining both the one-call and build-it-yourself paths.

Read the full simtrial trajectory →

pharmaverseadam vs simtrial: editorial side-by-side

P0.0

pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.

◆ Current state

pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.

◆ Where it's heading

Coverage tracks the pharmaverse's own therapeutic-area expansion with a lag of one release: pediatrics arrived in 1.1.0, metabolic in 1.2.0, neurology in 1.3.0. The other consistent thread is a slow move off development versions — 1.1.0 and 1.2.0 both had to pin unreleased upstream builds to get working templates, while 1.3.0 cites released versions throughout. Reorganising the reference page by therapeutic area is the same maturation showing up in documentation.

◆ Prediction

Expect the next release to follow the established pattern — a refresh against current upstream versions plus datasets from whichever admiral therapeutic-area package reaches a stable release next.

S
simtrial
ANALYTICS
0.0

A fixed-design trial simulator grew a pluggable test framework, then spent a year proving the numbers

◆ Current state

simtrial simulates time-to-event clinical trials and applies the tests used to analyse them — logrank, weighted logrank, MaxCombo, RMST, milestone. The 0.4.0 release turned it from a fixed-sample simulator into a group sequential one and standardised every test behind a common output contract, and the releases since have been about making that machinery correct and fast enough to run at scale. Version 1.0.0 arrived in June 2025 with the API settled and three vignettes explaining both the one-call and build-it-yourself paths.

◆ Where it's heading

Post-1.0 the work is almost entirely statistical correctness and speed, and it is concentrated in sim_gs_n(): one-sided efficacy bounds, stratified targeted-event cut dates, a helper that derives cuttings straight from the design object. Performance moves in one direction throughout — dplyr replaced by data.table, foreach combination replaced by manual assembly, parallelisation added to sim_fixed_n() — because simulation-based operating characteristics are only useful if you can afford enough replications.

◆ Prediction

The recent fixes cluster on stratified and group sequential paths, so the next release most likely continues there rather than adding a new test type. The cut_from_design() helper suggests tighter coupling to gsDesign2 design objects is the direction of travel.

Alternatives to pharmaverseadam and simtrial

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either pharmaverseadam or simtrial.

See all pharmaverseadam alternatives → · See all simtrial alternatives →

Recent activity from pharmaverseadam and simtrial

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 5mo agopharmaverseadamNeurology and anti-drug antibody datasets added
  2. 8mo agosimtrialOne-sided efficacy bound and stratified cut date corrected
  3. 11mo agosimtrialsim_gs_n moved to data.table; stratified design example added
  4. 11mo agopharmaverseadamMetabolic therapeutic area datasets arrive
  5. 1y agosimtrial1.0.0 settles the wlr interface and documents both simulation paths
  6. 1y agosimtrialMilestone Z-score denominator corrected; parallel sim_fixed_n arrives
  7. 1y agopharmaverseadamPediatric ADVS added in an ad-hoc refresh
  8. 2y agopharmaverseadam1.0 declares the dataset collection stable
  9. 2y agosimtrialChecks pass without Suggests dependencies
  10. 2y agosimtrialRMST and milestone tests, plus a user-definable cut and test framework
  11. 2y agopharmaverseadamFirst release of the ADaM dataset collection

Frequently asked questions

What is the difference between pharmaverseadam and simtrial?

Both compete on the same themes — pharmaverse — within Analytics. pharmaverseadam and simtrial are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is pharmaverseadam better than simtrial?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. pharmaverseadam and simtrial are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to pharmaverseadam?

Top pharmaverseadam alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaverseadam alternatives" section above for the current picks, or visit /alternatives/pharmaverseadam for the full list with editorial commentary on each.

What are the best alternatives to simtrial?

Top simtrial alternatives in Analytics are ranked by recent ship velocity. Browse the "simtrial alternatives" section above for the current picks, or visit /alternatives/simtrial for the full list with editorial commentary on each.